Online citations, reference lists, and bibliographies.
← Back to Search

Palliative Chemotherapie Oder Doch Besser Palliative Care

M. Borner, D. Rauch
Published 2015 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Die palliative Tumortherapie und Palliative Care sind komplementare Bestandteile desselben Behandlungskomplexes. Die primaren Ziele einer palliativen Chemotherapie sind eine Verbesserung der Lebensqualitat und eine Verlangerung des Uberlebens. Kernanliegen der Palliative Care sind Symptommanagement, psycho­soziale, spirituelle, kommunikative Aspekte und eine Verbesserung der Entscheidungskompetenz der Patienten.
This paper references
10.1200/JCO.2004.08.136
Trends in the aggressiveness of cancer care near the end of life.
C. Earle (2004)
Relationship between cancer patients’ predictions of prognosis and their treatment
JC Weeks (1998)
10.1634/THEONCOLOGIST.11-10-1095
Chemotherapy given near the end of life by community oncologists for advanced non-small cell lung cancer.
J. R. Murillo (2006)
10.1200/JCO.2010.33.1744
American society of clinical oncology statement: toward individualized care for patients with advanced cancer.
J. Peppercorn (2011)
10.1056/NEJMC1107200#SA2
Bending the cost curve in cancer care.
K. Field (2011)
10.3949/CCJM.64.4.181
How to tell patients bad news: the strategy of "forecasting".
D. Maynard (1997)
10.1007/s10549-012-2218-y
Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physicians
F. Thiel (2012)
10.1097/PPO.0b013e3181f28ab3
Palliative Chemotherapy: When Is It Worth It and When Is It Not?
K. Swetz (2010)
10.1200/JCO.2005.07.003
Necessary collusion: prognostic communication with advanced cancer patients.
P. Helft (2005)
10.1136/bmj.321.7273.1376
Collusion in doctor-patient communication about imminent death: an ethnographic study
A. The (2000)
10.1056/NEJMp1215620
Generalist plus specialist palliative care--creating a more sustainable model.
T. Quill (2013)
10.1200/JCO.2012.45.5865
Explicit prognostic information and reassurance about nonabandonment when entering palliative breast cancer care: findings from a scripted video-vignette study.
Liesbeth M. van Vliet (2013)
10.7326/0003-4819-139-9-200311040-00021
Hope for the best, and prepare for the worst.
James D Brody (2003)
10.1136/bmj.300.6737.1458
Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.
M. Slevin (1990)
10.1024/0040-5930/a000256
[SENS is making sense - on the way to an innovative approach to structure Palliative Care problems].
S. Eychmüller (2012)
10.1001/archinternmed.2008.587
Health care costs in the last week of life: associations with end-of-life conversations.
B. Zhang (2009)
10.1023/A:1008270916325
The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: results of a phase III trial. Swiss Group for Clinical Cancer Research (SAKK).
M. Borner (1998)
10.1200/JCO.2005.03.6236
Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer.
R. Matsuyama (2006)
10.1200/JCO.2006.06.007
Discussing prognosis: "how much do you want to know?" talking to patients who are prepared for explicit information.
A. Back (2006)
10.1001/JAMA.290.15.2056
Complexities in prognostication in advanced cancer: "to help them live their lives the way they want to".
A. J. Markowitz (2003)
10.1200/JCO.2013.54.8149
Developing a service model that integrates palliative care throughout cancer care: the time is now.
A. Partridge (2014)
10.1200/JCO.2009.26.8870
Cancer patients' roles in treatment decisions: do characteristics of the decision influence roles?
N. Keating (2010)
10.1200/JCO.2004.04.095
Cancer patient preferences for communication of prognosis in the metastatic setting.
R. Hagerty (2004)
10.1016/S0140-6736(13)62416-2
Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial
C. Zimmermann (2014)
「緩和ケア」として行われた介入と副次的評価項目であることの限界 (論文を読み,理解する--Early palliative care for patients with metastatic non-small-cell lung cancer)
森田 達也 (2011)
10.1089/JPM.2013.0651
Reframing the Goals of Care Conversation: “We're in a Different Place”
L. BackAnthony (2014)
10.1056/NEJMc0911925
Capecitabine and oxaliplatin for advanced esophagogastric cancer.
D. Cunningham (2010)
10.1001/jama.299.22.2667
The role of chemotherapy at the end of life: "when is enough, enough?".
Sarah E. Harrington (2008)
10.1001/jama.300.14.1665
Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment.
A. Wright (2008)
10.1200/JCO.2010.33.2080
Can patient-reported outcome measures identify cancer patients' most bothersome issues?
C. Snyder (2011)
10.1200/JCO.2011.35.7996
Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer.
J. Greer (2012)
10.1016/S1470-2045(14)70330-4
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial.
V. Heinemann (2014)
10.1016/S0277-9536(98)00453-5
Information needs in terminal illness.
J. Kutner (1999)
10.1200/JCO.2006.06.0269
Patients' decision-making process regarding participation in phase I oncology research.
Manish Agrawal (2006)
10.1200/JCO.2010.29.5618
Integrating supportive and palliative care in the trajectory of cancer: establishing goals and models of care.
E. Bruera (2010)
10.1001/JAMA.279.21.1709
Relationship between cancer patients' predictions of prognosis and their treatment preferences.
J. Weeks (1998)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar